Form 8-K - Current report:
SEC Accession No. 0000950170-25-074523
Filing Date
2025-05-19
Accepted
2025-05-19 17:02:22
Documents
10
Period of Report
2025-05-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20250514.htm   iXBRL 8-K 86763
  Complete submission text file 0000950170-25-074523.txt   190522

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20250514.xsd EX-101.SCH 23908
12 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20250514_htm.xml XML 4516
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 25964920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)